Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.

Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.

Exercise Training Modulates Gut Microbiota Profile and Improves Endotoxemia.

Determinants of aspirin resistance in patients with type 2 diabetes.

Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.

Erythrocyte n-6 Polyunsaturated Fatty Acids, Gut Microbiota, and Incident Type 2 Diabetes: A Prospective Cohort Study.

Impact of Diabetes on the Gut and Salivary IgA Microbiomes.

The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes.

Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.

[Correlation analysis between type 2 diabetes and core gut microbiota].

Gut microbiome differences among Mexican Americans with and without type 2 diabetes mellitus.

Evaluation of salusin-α and salusin-β levels in patients with type 2 diabetes mellitus and determination of the impact of severity of hyperglycemia on salusin levels.

Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.

Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies.

Oral Cyanobacteria and Hepatocellular Carcinoma.

Habitual Dietary Fiber Intake, Fecal Microbiota, and Hemoglobin A1c Level in Chinese Patients with Type 2 Diabetes.

Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.

Gut microbiota mediate melatonin signalling in association with type 2 diabetes.

Gut microbiota analyses of Saudi populations for type 2 diabetes-related phenotypes reveals significant association.

Gut Microbiota and Serum Metabolites in Individuals with Class III Obesity Without Type 2 Diabetes Mellitus: Pilot Analysis.

Metagenome Investigation of Ocular Microbiota of Cataract Patients With and Without Type 2 Diabetes.

Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers.

Comparative study of type 2 diabetes mellitus-associated gut microbiota between the Dai and Han populations.

Gut microbiota and metabolites exhibit different profiles after very-low-caloric restriction in patients with type 2 diabetes.

Metformin Alters mRNA Expression of FOXP3, RORC, and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes.

Alterations in the Gut Microbiota Composition in Obesity with and without Type 2 Diabetes: A Pilot Study.

Fecal Microbiome and Urine Metabolome Profiling of Type 2 Diabetes.

Intestinal Microbiota Composition in Patients with Type 2 Diabetes and Effects of Oral Antidiabetics.

Fecal microbiome analysis in patients with metabolic syndrome and type 2 diabetes.

The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short-Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case-Control Study.

Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients.

Protein supplementation changes gut microbial diversity and derived metabolites in subjects with type 2 diabetes.

Relationship between plasma leucine-rich α-2-glycoprotein 1 and urinary albumin excretion in patients with type 2 diabetes.

Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study.

Both PAX4 and MAFA are expressed in a substantial proportion of normal human pancreatic alpha cells and deregulated in patients with type 2 diabetes.

TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.

RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes.

Role of wnt5a in Metabolic Inflammation in Humans.

Quantification of TNF-α in Patients with Periodontitis and Type 2 Diabetes.

Response of gut microbiota in type 2 diabetes to hypoglycemic agents.

Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.

Oxidative stress and inflammatory markers in type 2 diabetic patients.

Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes.

Conjunctival Microbiota in Patients With Type 2 Diabetes Mellitus and Influences of Perioperative Use of Topical Levofloxacin in Ocular Surgery.

Carotenoid status in type 2 diabetes patients with and without retinopathy.

Effects of type 2 diabetes and metformin on salivary microbiota in patients with chronic periodontitis.

Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity.

Estrogen receptor α activation modulates the gut microbiome and type 2 diabetes risk factors.

Peroxisome Proliferator-Activated Receptor-α (PPARα) Expression in a Clinical Population of Pakistani Patients with Type 2 Diabetes and Dyslipidemia.

Association of intestinal microbiota markers and dietary pattern in Chinese patients with type 2 diabetes: The Henan rural cohort study.

Alterations of the gut microbiota in type 2 diabetics with or without subclinical hypothyroidism.

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment.

TCF7L2 and FTO Polymorphisms Are Associated with Type 2 Diabetes Mellitus Risk in Kuwait.

Relationships of serum FGF23 and α-klotho with atherosclerosis in patients with type 2 diabetes mellitus.

Impact of nocturnal hypoxia on glycaemic control, appetite, gut microbiota and inflammation in adults with type 2 diabetes mellitus: A single-blind cross-over trial.

In-depth Microbiological Characterization of Urine From Subjects With Type 2 Diabetes.

Tangerine Peel-Derived Exosome-Like Nanovesicles Alleviate Hepatic Steatosis Induced by Type 2 Diabetes: Evidenced by Regulating Lipid Metabolism and Intestinal Microflora.

Salivary microbiome variations in type 2 diabetes mellitus patients with different stages of periodontitis.

Comparative analysis of TNF-α (-308) gene polymorphism in Turkish patients with type 2 diabetes developing nephropathy and/or neuropathy.

Mulberry leaf improves type 2 diabetes in mice via gut microbiota-SCFAs-GPRs axis and AMPK signaling pathway.

The liver in obesity and type 2 diabetes mellitus.

Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.

Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.

Noninsulin treatment of type 2 diabetes mellitus in geriatric patients: a review.

Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus.

Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.

The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.

Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity.

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential.

Relationships between type 2 diabetes, cell dysfunction, and redox signaling: A meta-analysis of single-cell gene expression of human pancreatic α- and β-cells.

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice.

Gut microbiome and health: mechanistic insights.

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus.

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.

The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.

Effects of Exercise on Circulating Muscle-related Cytokines in Adults with Type 2 Diabetes and/or Obesity.

The Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor?

Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges.

The human α cell in health and disease.

Early-life exposure to the Great Chinese Famine and gut microbiome disruption across adulthood for type 2 diabetes: three population-based cohort studies.

Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease.

Impact of Dietary Fiber on Inflammation in Humans.

Glucose Parameters, Inflammation Markers, and Gut Microbiota Changes of Gut Microbiome-Targeted Therapies in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Systematic Review on the Importance of Gut Microbiota in the Regulation of Type 2 Diabetes Through Physical Activity and Exercise.

Exercise-induced modulation of gut microbiota in individuals with obesity and type 2 diabetes: a systematic review and meta-analysis.

Gut Microbiota Modulation in Type 2 Diabetes and Cardiometabolic Risk: A Systematic Review.

Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials.

Gut microbiota and type 2 diabetes associations: a meta-analysis of 16S studies and their methodological challenges.